Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis

Lars Lundell(Karolinska Institutet), A. Walan(Linköping University), Pekka Miettinen(Kuopio University Hospital), Jan Gunnar Hatlebakk(Haukeland University Hospital), Madeline C. Montgomery(Beth Israel Deaconess Medical Center), Tore Lind(Skaraborg Hospital), H. E. Myrvold(St Olav's University Hospital), Cecilia Engström(Sahlgrenska University Hospital), Anders Malm(AstraZeneca (Sweden)), Risto Julkunen(Kuopio University Hospital), L. Wallin(Odense University Hospital)
Clinical Gastroenterology and Hepatology
June 1, 2009
10.1016/j.cgh.2009.05.021
Cited by 150

Related Papers

Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
|Helicobacter|1996|575
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
|Gastroenterology|2000|544
A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.
|Gastroenterology|2004|526
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
|Gastroenterology|1999|433
Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
|New England Journal of Medicine|1989|382